心血管疾病和慢性肾病。 - Suppr

Suppr

超能文献

Cardiovascular disease and chronic kidney disease.

作者信息

Gargiulo Richard, Suhail Faten, Lerma Edgar V

出版信息

Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29.

DOI:10.1016/j.disamonth.2015.07.005

PMID:26328516

Abstract

摘要

相似文献

Cardiovascular disease and chronic kidney disease.

Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29.

[Chronic kidney disease--update 2014].

Dtsch Med Wochenschr. 2014 Feb;139(6):261-3. doi: 10.1055/s-0033-1360018. Epub 2014 Jan 28.

[Cardiovascular disease in patients with 4 and 5 stage chronic kidney disease. Patient in chronic dialysis].

Nefrologia. 2004;24 Suppl(6):142-60, 187-235.

Epicardial adipose tissue: A cardiovascular risk marker to evaluate in chronic kidney disease.

Clin Investig Arterioscler. 2020 May-Jun;32(3):129-134. doi: 10.1016/j.arteri.2019.10.006. Epub 2020 Jan 21.

Kidney disease and cardiovascular risk.

Annu Rev Med. 2007;58:123-39. doi: 10.1146/annurev.med.58.071105.111123.

It's about time: extending our understanding of cardiovascular risk from chronic kidney disease.

J Am Soc Nephrol. 2009 Dec;20(12):2486-7. doi: 10.1681/ASN.2009101045. Epub 2009 Nov 5.

Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.

J Nephrol. 2006 May-Jun;19(3):246-58.

[Chronic renal insufficiency and cardiovascular disease].

Ann Cardiol Angeiol (Paris). 2009 Feb;58(1):40-52. doi: 10.1016/j.ancard.2008.07.010. Epub 2008 Aug 19.

Author's reply: To PMID 23618914.

J Cardiol. 2014 Sep;64(3):242. doi: 10.1016/j.jjcc.2014.01.008. Epub 2014 Apr 13.

What happens to the heart in chronic kidney disease?

J R Coll Physicians Edinb. 2017 Mar;47(1):76-82. doi: 10.4997/JRCPE.2017.117.

引用本文的文献

Causal relationship between cardiovascular diseases and vestibular dysfunction: A 2-sample Mendelian randomization study.

Medicine (Baltimore). 2025 Jul 18;104(29):e43091. doi: 10.1097/MD.0000000000043091.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Cochrane Database Syst Rev. 2023 Nov 29;11(11):CD007784. doi: 10.1002/14651858.CD007784.pub3.

The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients.

Diabetes Metab J. 2023 May;47(3):415-425. doi: 10.4093/dmj.2022.0177. Epub 2023 Mar 6.

The roles of sodium and volume overload on hypertension in chronic kidney disease.

Kidney Res Clin Pract. 2021 Dec;40(4):542-554. doi: 10.23876/j.krcp.21.800. Epub 2021 Nov 17.

The Complexity of FGF23 Effects on Cardiomyocytes in Normal and Uremic Milieu.

Cells. 2021 May 20;10(5):1266. doi: 10.3390/cells10051266.

The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients.

Sci Rep. 2021 Feb 15;11(1):3786. doi: 10.1038/s41598-021-83383-x.

Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Clin Pharmacol Ther. 2021 Jun;109(6):1593-1605. doi: 10.1002/cpt.2131. Epub 2021 Jan 19.

Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα): New Opportunities to Reduce Residual Cardiovascular Risk in Chronic Kidney Disease?

Curr Atheroscler Rep. 2020 Jul 15;22(8):43. doi: 10.1007/s11883-020-00860-w.

Targeting Vascular Calcification in Chronic Kidney Disease.

JACC Basic Transl Sci. 2020 Apr 27;5(4):398-412. doi: 10.1016/j.jacbts.2020.02.002. eCollection 2020 Apr.

Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease.

BMC Geriatr. 2020 Mar 4;20(1):87. doi: 10.1186/s12877-020-1485-4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验